WSI Past Earnings Performance
Past criteria checks 1/6
WSI has been growing earnings at an average annual rate of 10.5%, while the Healthcare industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 6.6% per year. WSI's return on equity is 2.2%, and it has net margins of 2.9%.
Key information
10.5%
Earnings growth rate
8.7%
EPS growth rate
| Healthcare Industry Growth | 34.2% |
| Revenue growth rate | 6.6% |
| Return on equity | 2.2% |
| Net Margin | 2.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How WSI makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 36,903 | 1,067 | 6,980 | 342 |
| 30 Jun 24 | 31,920 | 1,606 | 6,624 | 155 |
| 31 Mar 24 | 31,422 | 2,267 | 6,482 | 180 |
| 31 Dec 23 | 30,877 | 2,877 | 6,285 | 179 |
| 30 Sep 23 | 30,210 | 2,712 | 5,833 | 169 |
| 30 Jun 23 | 29,347 | 3,679 | 5,353 | 167 |
| 31 Mar 23 | 27,420 | 4,253 | 5,941 | 100 |
| 31 Dec 22 | 27,129 | 4,368 | 5,587 | 97 |
| 30 Sep 22 | 27,384 | 7,886 | 5,304 | 96 |
| 30 Jun 22 | 27,199 | 7,664 | 5,057 | 94 |
| 31 Mar 22 | 28,063 | 7,105 | 3,944 | 116 |
| 31 Dec 21 | 27,776 | 7,175 | 3,713 | 102 |
| 30 Sep 21 | 27,247 | -2,199 | 3,495 | 129 |
| 30 Jun 21 | 27,203 | -1,715 | 3,326 | 110 |
| 31 Mar 21 | 27,071 | -1,208 | 2,991 | 68 |
| 31 Dec 20 | 26,386 | -1,640 | 3,063 | 105 |
| 31 Dec 19 | 23,721 | 3,527 | 3,290 | 212 |
| 31 Dec 18 | 22,763 | 4,099 | 2,876 | 23 |
Quality Earnings: A299170 has a large one-off loss of ₩2.0B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: A299170's current net profit margins (2.9%) are lower than last year (9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A299170's earnings have grown by 10.5% per year over the past 5 years.
Accelerating Growth: A299170's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A299170 had negative earnings growth (-60.7%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).
Return on Equity
High ROE: A299170's Return on Equity (2.2%) is considered low.